Scinovex
article Open Access

Efficacy of single dose of zoledronic acid in treating post-menopausal osteoporosis

International Journal of Orthopaedics Sciences · 2019 · Vol. 5(4) · pp. 364–368
Sandeep KumarP VasanthamaniS Makesh RamDr C Srinivasa CholanKathirazhagan S

Abstract

 The purpose of this study is to analyse the effect of single dose of zoledronic acid in treating post-menopausal osteoporosis.Aim of the study To show the significance increase in bmd with zoledronic acid infusion in single dose. Materials Study design - prospective study. Study population - patients attending opd in department of orthopaedics with osteoporosis evaluated by bone mineral density (bmd) scan in govt. kilpaukmedical college hospital. Duration of study – 1 year  After patients were screened with peripheral BMD densitometry patient were selected then they were subjected to do bmd dexa scan to confirm osteoporosis. Those who were in osteoporotic group were included in our study. Method After patient is evaluated, they were instructed to drink 500ml-1000ml of water for hydration.  Then single dose of Zoledronic acid in 100 ml of Normal saline was infused intravenously over 15 mins.  Patient were observed for two hours then were discharged with prophylactic Paracetamol tablets.

Bone health and treatmentsBone health and osteoporosis researchMedicineZoledronic acidOsteoporosisDensitometryBone mineralSalineOrthopedic surgeryProspective cohort studyBisphosphonateSurgery
Citations
0
FWCI
0.00
field-weighted impact
References
8
Percentile
19%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.